Independent Director · Zentalis Pharmaceuticals, Inc. (ZNTL)

Chair, Nominating/Governance Committee

Jan Skvarka, Ph.D director compensation at Zentalis (FY2025): $151K

Fiscal year 2025 director compensation for Jan Skvarka, Ph.D at Zentalis Pharmaceuticals, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 30, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Jan Skvarka, Ph.D’s full pay file as a PDF — free

More than this page: up to 10 years of Jan’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Jan Skvarka, Ph.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Zentalis Pharmaceuticals Director Compensation Table · all 3 fiscal years held
In US dollars, as Zentalis Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$65,000$86,405$0$0$151,405
FY2024$65,000$197,510——$262,510
FY2022$18,587$1,088,296——$1,106,883

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Zentalis Pharmaceuticals, Inc. DEF 14A filed April 30, 2026, accession 0001725160-26-000027, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Zentalis Pharmaceuticals, Inc. filed document, accession 0001725160-26-000027. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.

Get the Zentalis Pharmaceuticals Board Governance Report

$151,405 Jan Skvarka, Ph.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 30, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Zentalis Pharmaceuticals pays directors a $45,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Audit · Compensation · Nominating/Governance (Chair)

The rest of the Zentalis Pharmaceuticals board

FY2025 · as the company reported each
DirectorRoleFY2025 total
David JohnsonIndependent Director$139,251
Enoch Kariuki, Pharm.DIndependent Director$151,405
Julie EastlandDirector—
Luke Walker, M.DIndependent Director$145,266
Scott MyersIndependent Director$184,136

The full Zentalis Pharmaceuticals compensation record

free company brief

This page is one director within Zentalis Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Zentalis Pharmaceuticals proxy · each links to its own free brief

Order ZNTL

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report